Apimeds Pharmaceuticals US
We are a clinical biopharmaceutical company developing an anti-inflammatory treatment derived from bee venom. (Incorporated in Delaware) We are developing Apitox, an intradermal treatment derived from bee venom, to treat inflammation and pain associated with osteoarthritis of the knee. Apimeds, a subsidiary of Inscobee, markets and sells Apitox in South Korea. We are pursuing a […]
October 4, 2024 Read More